Alexza Pharma (ALXA) Tops Q3 EPS by 7c

Alexza Pharma (NASDAQ: ALXA) reported Q3 EPS of ($0.27), $0.07 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $1.77 million versus the consensus estimate of $1.6 million.

For earnings history and earnings-related data on Alexza Pharma (ALXA) click here.

You May Also Be Interested In

• Investing.com’s stocks of the week
• Home Federal Bancorp of Louisiana (HFBL) Tops Q2 EPS by 46c
• Arbor Realty Trust (ABR) Tops Q2 EPS by 4c